The Weill Cancer Hub East unites Princeton University, Rockefeller University, Weill Cornell Medicine, and the Ludwig Institute for Cancer Research with a mission to revolutionize cancer treatment. A significant $50 million endowment from the Weill Family Foundation, enhanced to over $125 million

A landmark achievement in quantum computing has been reached, promising to revolutionize technology and digital security. Quantum computers use qubits, capable of superposition, transcending traditional binary systems and exponentially boosting computing power. Researchers successfully utilized a 56-qubit quantum computer to generate and

Top U.S. officials’ use of Signal for sensitive discussions raises national security concerns. Defense Secretary Pete Hegseth and Director of National Intelligence Tulsi Gabbard were involved in this security lapse. The inclusion of a journalist in confidential talks highlighted risks associated with

Financial markets are unsettled following the announcement of 25% tariffs on imported automobiles, contributing to market retreats and global trade concerns. Uncertainty reigns as investors await “Liberation Day” on April 2, with noted apprehension from market analysts, including Jeff Marks and Morgan

IonQ’s stock dropped 53% due to recent developments, sparking debate over its value as a quantum computing pioneer. Alphabet’s breakthrough with the Willow quantum chip highlighted the gap between visionary innovation and practical application. Nvidia’s perspective suggests a commercially usable quantum computer

Merck introduces an injectable form of Keytruda, potentially transforming cancer treatment with a two-minute administration. The FDA is reviewing this subcutaneous injection, which matches the efficacy of the current IV format. This new method drastically reduces treatment time from two hours to

Groundbreaking research highlights glutamate as a key driver in liver regeneration, revealing its role beyond neural messaging. Hepatocytes release glutamate following liver injury, activating monocytes that mature into macrophages to aid healing. Glutamate balances with glutamine synthetase to precisely control liver repair,

Unisys launches a Post-Quantum Cryptography (PQC) service to counteract emerging quantum threats. The service assesses vulnerabilities in current systems to enhance digital defenses globally. The urgency stems from the potential of quantum computers compromising existing cryptographic protections. Unisys provides a comprehensive suite

Rina-S, an investigational drug in phase 2 trials, shows promise for advanced ovarian cancer patients with limited treatment options. The drug targets folate receptor alpha (FRα) on malignant cells, sparing healthy tissue. Significant results from the RAINFOL-01 study indicate a 55.6% confirmed